Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kathleen Roberta Bell has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Sodium-Struggle Hypothesis of Autism: A Sodium–Volume Defence Systems Physiology Framework

    by Kathleen Bell

    The Sodium–Volume Defence Hypothesis or Sodium–Struggle Hypothesis of Autism frames a substantial subset of autism not as the consequence of clinical hyponatraemia in the narrow laboratory sense but as a developmental imprint of recurrent movement toward low-effective sodium pressure along the sodium–volume survival axis. The core claim is that vertebrate physiology does not defend serum sodium as an isolated number. It defends a coupled survival geometry in which sodium-weighted support of extracellular tonicity, effective arterial volume, tissue perfusion, and cellular viability must remain coherent enough to prevent collapse. In this framework, “effective sodium” is shorthand for sodium’s functional contribution to extracellular stability, not a new laboratory analyte. Low-effective sodium therefore names a physiological state in which sodium’s contribution to tonicity, volume support, or perfusion-effective distribution becomes fragile, misweighted, or repeatedly threatened even when measured serum sodium remains within the reference range. Clinical hyponatraemia remains a real initiating route, but it is not the defining requirement. The defining requirement is repeated recruitment of defence systems before overt collapse occurs, followed by incomplete reset during fetal and early postnatal calibration windows. The hypothesis is thus about the history of rescue, not the chemistry panel captured at one moment. It is organised around a non-teleological principle of survival prioritisation. When physiology approaches a state in which extracellular stability, pressure, or perfusion may fail, the organism does not optimise for later developmental precision. It triages for immediate viability. AVP, RAAS, autonomic vasomotor recruitment, glucocorticoid support, renal sodium and water conservation, and cellular volume-preserving transport strategies are mobilised because death from perfusion failure is immediate, whereas long-horizon refinement of inhibitory timing and circuit pruning can be deferred. What is proposed to persist is not chronic dysnatraemia but developmental imprinting across endocrine, vascular, renal, autonomic, hypothalamic, glial, and ion-transport systems. This framing makes the Sodium Paradox central rather than peripheral. The Sodium Paradox is the possibility of normal or high osmolality with functional sodium insufficiency. Sodium can be functionally inadequate even when total osmolality is preserved or elevated because the relevant issue is not osmolality alone but which osmoles are carrying it, how water is distributed, whether the intravascular fraction is perfusion-effective, and whether regulatory systems read the state as coherent or unstable. A translocational or osmotic mismatch arises when glucose or other non-ionic osmoles raise osmolality and move water across compartments faster than sodium is re-equilibrated. A dilutional state can coexist with underfilling when water expansion does not translate into stable effective arterial volume. Endocrine mismatch can occur when fluid consequences are transmitted but peptide rescue is filtered or delayed. The result is a physiologically credible condition in which serum sodium may appear acceptable, osmolality may be normal or high, yet tissues and controllers still confront low-effective sodium. This is why the hypothesis insists on distinguishing clinical hyponatraemia from functional sodium insufficiency, and on distinguishing dilution from perfusion failure from translocational states rather than collapsing them into one category. The maternal side of the hypothesis begins with the observation that pregnancy is an exercise in defending coupled tonicity, volume, perfusion, and placental conductance under changing load. Maternal physiology may encounter dilution-prone inputs, glycaemic oscillations, vascular underfilling, placental resistance, inflammatory endothelial leak, altered oncotic balance, or pharmacologically induced antidiuresis. Low-TDS or other solute-poor water intake is treated cautiously but explicitly within this model as one plausible contributor to dilution-prone states, particularly when consumed in volume or when infant feeds are prepared with very low-solute water. The claim is not that low-TDS water is a universal cause, but that fluid which expands water more readily than ionic support can, under the right conditions, push the system toward true dilution. Gestational diabetes and repeated glucose excursions represent a distinct but convergent route. Here total osmolality may rise, yet the rise is carried in part by glucose rather than sodium, producing oscillatory osmotic stress and translocational water shifts that can yield functional low-effective sodium in the fetal readout. Highly bioavailable inorganic phosphate additives provide another modern route. By increasing phosphate load and contributing to hyperphosphataemia, FGF-23 signalling, phosphaturia, vascular stiffening, and nitric-oxide-limiting states, they can redistribute sodium handling across nephron segments, reduce proximal sodium reclamation, and add a downstream sodium-handling burden even without classic salt loss. Selected medication-related dilutional states enter the same geometry more briefly but importantly: SSRIs, thiazide-like states, oxytocin with hypotonic carriers, and other water-retentive conditions can create transient but developmentally relevant fluid–solute imbalance. These are not presented as equal in effect size or certainty. They are presented as convergent entry routes into the same control problem. The placenta is the decisive hinge because the fetus does not receive maternal physiology directly. The placenta transforms rather than replicates maternal signals. It is a transport epithelium, endocrine filter, peptide-metabolising barrier, vascular regulatory surface, and timing transformer. Water transfer is rapid and follows osmotic gradients...

  • Open Access

    Association between obesity and combination antiretroviral therapy (cART) adherence among persons with early-stage HIV infection initiating cART

    by Nicholas Musinguzi, Fatima Cody Stanford, Adeline A. Boatin, Catherine Orrell, Stephen Asiimwe, Mark Siedner, Jessica E. Haberer, on behalf of the META team, Bosco M. Bwana, Gideon Amanyire, et al.

    Background Obesity is common among people living with HIV (PLWH) and early-stage infection, yet associations with combination antiretroviral (cART) adherence are unclear. Methods Among PLWH initiating cART in Uganda and South Africa, body mass index (BMI) was assessed at cART initiation, and cART adherence was monitored in real-time over 12 months. The association of obesity (BMI ≥ 30 kg/m2) with adherence was assessed among nonpregnant participants with CD4 > 350 cells/mm3 using fractional regression modeling. Results Among 322 participants, median age was 32 years, 70% were female, and 54% were from Uganda. Prevalence of obesity was 12% in Uganda and 28% in South Africa. Mean overall cART adherence was 83% in Uganda and 66% in South Africa. Participants with obesity had higher adherence than those without obesity: +3.6% (p = 0.44) in Uganda and +11.4% (p = 0.02) in South Africa. Conclusion Obesity at cART initiation was common and associated with higher adherence, although only significantly in South Africa.


  • Open Access

    Postnatal Acetaminophen and Potential Risk of Autism Spectrum Disorder among Males

    by Seth S. Bittker, Kathleen R. Bell

    Some evidence from the literature suggests that postnatal acetaminophen exposure may be associated with increased risk of autism spectrum disorder (ASD). Using a data set obtained from a previous study that was derived from an Internet-based survey among parents on 1515 children from the US, an adjusted odds ratio (aOR) and gender-specific aORs for doses of postnatal acetaminophen provided before age two were calculated against the outcome of ASD. Separately, parental uncertainty on the number of doses of acetaminophen provided was analyzed. A population attributable fraction (PAF) associated with postnatal acetaminophen exposure before age two for ASD among males was also estimated. Postnatal acetaminophen exposure, measured in doses before age two, was found to be associated with ASD among male children (aOR 1.023, CI 1.005–1.043, p = 0.020*), and parental uncertainty on the number of doses of acetaminophen provided before age two was also found to be associated with ASD. Using this data set, the PAF associated with postnatal acetaminophen was estimated to be about 40% of the risk of ASD among male children in the US. These results suggest the possibility that postnatal acetaminophen may be a significant contributor to the risk of ASD among males in the US.


  • Open Access

    Potential risk factors for celiac disease in childhood: a case-control epidemiological survey

    by Seth Scott Bittker, Kathleen Roberta Bell

    Background: Celiac disease (CD) prevalence has increased significantly in recent decades in some developed countries. Yet the environmental factors in the existing literature do not appear to provide a satisfactory explanation for this increase. Objective: To determine whether nine variables are associated with CD in children. These variables are: incidence of ear infection before 2 years old, courses of antibiotics before 2 years old, duration of breastfeeding, vitamin D drop exposure in infancy, vitamin D supplement exposure between 2–3 years old, age at gluten introduction into the diet, fat content of cow’s milk consumed between 2–3 years old, quantity of cow’s milk consumed between 2–3 years old, and type of water consumed at 2 years old. Methods: An Internet-based survey was conducted among parents living in the US with at least one biological child between 3 and 12 years old. Potential participants were informed about the survey through social media, websites, electronic newsletters, and advertisements. Results: After exclusions, there remained 332 responses associated with children with CD (cases), and 241 responses associated with children who do not have CD (controls). In this data set, skim milk as the primary form of liquid cow’s milk consumed between 2–3 years old (adjusted odds ratio [aOR]=3.556, CI=1.430–10.22, P=0.010), vitamin D drops administered for more than 3 months (aOR=1.749, CI=1.079–2.872, P=0.025), courses of antibiotics (aOR=1.133, CI=1.037–1.244, P=0.007), and incidence of ear infection (aOR=1.183, CI=1.041–1.348, P=0.010) are all associated with CD in children. Conclusions: This study is the first to find an association between skim milk consumption and CD and vitamin D drop use for greater than 3 months and CD. It also adds to evidence that early life exposure to antibiotics and early life infection, specifically ear infection, are associated with CD.


  • Open Access

    Acetaminophen, antibiotics, ear infection, breastfeeding, vitamin D drops, and autism: an epidemiological study

    by Seth Scott Bittker, Kathleen Roberta Bell

    Background: While many studies have examined environmental risk factors for autism spectrum disorder (ASD), much of the research focus has been on prenatal or perinatal factors. Yet, the postnatal environment may affect the risk of ASD as well. Objective: To determine whether a set of five postnatal variables are associated with ASD. These variables are: acetaminophen exposure, antibiotic exposure, incidence of ear infection, decreased duration of breastfeeding, and decreased consumption of oral vitamin D drops. Materials and methods: An Internet-based survey was conducted. Participants were parents living in the USA with at least one biological child between 3 and 12 years of age. Potential participants were informed about the survey via postings on social media, websites, and listservs and were offered an opportunity to participate in a raffle as well. Participants were also recruited through the Interactive Autism Network. Results: There were 1,741 completed survey responses. After exclusions, there remained 1,001 responses associated with children with ASD (cases) and 514 responses associated with children who do not have ASD (controls). In this data set, doses of postnatal acetaminophen (adjusted odds ratio [aOR] 1.016, CI: 1.003–1.032, p=0.026), courses of postnatal antibiotics (aOR 1.103, CI: 1.046–1.168, pp=0.003), and decreased duration of breastfeeding (aOR 0.948, CI: 0.932–0.965, pp=0.102). Conclusion: This study adds to evidence that postnatal acetaminophen use, postnatal antibiotic use, incidence of ear infection, and early weaning are associated with an increased risk of ASD. It also finds that postnatal oral vitamin D drops are weakly associated with ASD when adjusted for breastfeeding and demographics.